Stuart Silverman M.D. is a rheumatology physician, cannabis clinician and researcher in private practice who is a clinical Professor at both Cedars Sinai Medical Center and the David Geffen School of Medicine at UCLA. He is a faculty member of the UCLA Cannabis Research Initiative.
He has spoken on the topic of cannabis at venues ranging nationally from Princeton University to locally at TEC-Leimert and giving Grand Rounds on cannabis at both Cedars Sinai and UCLA. He is the author of over 200 peer reviewed original papers. He has served as director of the Cedars Sinai outpatient Fibromyalgia Rehab program and Acting Chief of Rheumatology at West Los Angeles VA Medical Center.
He has served on the Scientific Advisory Board of Kalytera Pharma, which is developing CBD and cannabinoids for treatment of disease, and has worked with Niamedic, an Israeli healthcare and research company specialized in integrating medical cannabis treatments.
He is part of a diversity initiative at UCRI and has started qualitative research on the cannabis journey in different racial/ethnic groups as well as working with UCRI on educational initiatives. He has received the Health Network Service Excellence award for his clinical research and practice which include chronic pain, fibromyalgia and osteoporosis.
He is a graduate of Princeton University, Johns Hopkins medical school and completed his medical training in internal medicine at Boston University. He is board certified in internal medicine, rheumatology and immunology. In his rheumatology practice he helps patients with rheumatologic conditions with chronic pain. He helps patients decrease opioid dependence with use of cannabis and both pharmacologic and non-pharmacologic management.